DUBLIN, Dec. 1, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/nq5t4v/global_mouth) has announced the addition of the "Global Mouth Ulcer Treatment Market 2015-2019" report to their offering.
According to the report, the prevalence of mouth ulcers is increasing, with 15-30% of the global population now affected by them. The factors contributing to this increase include trauma, stress, foods, hormonal imbalances, and tobacco smoking. Mouth disorders are also common among the aging population.
According to the WHO, approximately 2 billion people will be aged 60 years or older by 2050. As the prevalence of mouth ulcers increases, the number of people seeking treatment will also rise, thereby leading to the growth of the market.
The report forecasts the global mouth ulcer treatment market to grow at a CAGR of 4.18% over the period 2014-2019.
A single medication that relieves all mouth ulcer associated conditions does not yet exist. Hence, the use of multiple classes of drugs for treatment is in use, including pain relievers such as Anbesol, Num-Zit, and Zilactin-B; antisepsis drugs such as Peridex, and Orajel; and anti-inflammatory drugs such as Aphthasol and Orabase-HCA. This results in market fragmentation, affecting market growth.
Further, the report states that individuals are less inclined towards using drugs to treat mouth ulcers, which negatively affects the growth of the market.
Key questions answered in this report:
- What will the market size be in 2019 and what will the growth rate be?
- What are the key Market trendss?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
- 3M Healthcare
- Church & Dwight
- Taro Pharmaceuticals
- Valeant Pharmaceuticals
Other prominent vendors:
- Blairex Laboratories
- Bristol-Myers Squibb
- EPIEN Medical
- Focus Pharmaceuticals
- Henry Schein
- Macoven Pharmaceuticals
- Meda pharmaceuticals
- Sinclair IS Pharma
- Svizera Labs
- Zila Pharmaceuticals
For more information visit http://www.researchandmarkets.com/research/nq5t4v/global_mouth
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets